Innovation Drives Zoetis

ANALYSIS - Gloria Basse, Group Director - US Pork, discusses two innovations from Zoetis - a vaccine for swine flu and their introduction of a product that is an alternative to physical castration in male pigs, writes Sarah Mikesell, ThePigSite senior editor.

3 June 2013

2 minute read

By: Sarah Mikesell

North America

Basse explains how Zoetis brought their swine flu vaccine to the US market in record time - four months - rather than the 17-24 months it usually takes.

She also expands on Zoetis' recent US launch of Improvest (Improvac in other markets) which works with the pigs own immune system to eliminate boar taint.

Sarah Mikesell

Editor

Sarah Mikesell grew up on a five-generation family farming operation in Ohio, USA, where her family still farms. She feels extraordinarily lucky to get to do what she loves - write about livestock and crop agriculture. You can find her on Twitter or LinkedIn.